Back to ALPMY
Phase 2
Development Phase
1
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
Upcoming Catalysts
What are catalysts?Competitive Landscape
2 competitors in Metastatic Castration-Resistant Prostate Cancer
View Full LandscapeDrug Information
Target Indication
Metastatic Castration-Resistant Prostate Cancer
Clinical Trial
NCT04986423Last updated: 9/17/2026
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
